Results
iSERA Lifesciences FY26 Results with Rights Issue
Board approved audited standalone financial results for Q4 and year ended March 31, 2026, reporting revenue of ₹135.50 lakhs and net profit of ₹25.94 lakhs.
Company completed a rights issue of 80,85,5
